A large-scale clinical study from The National Cancer Institute (NCI) demonstrated that x-ray CT screening sharply reduced lung cancer deaths by detecting cancers at relatively early stages. Patients screened with x-ray CT were 20% less likely to die from lung cancer. Annual screening by x-ray CT detects lung cancers in their earliest stage, when survival is most promising. However, the study also showed that low-dose CT scans tend to have a high false positive rate.

A major milestone for lung cancer, the Centers for Medicare and Medicaid approved reimbursing low-dose CT scans in a high-risk group of patients (ages 55-77 who have smoked one pack of cigarettes a day for 30 years) in February 2015.

About LuCED®

LuCED does not use radiation. Rather, it uses a sputum sample that can be collected through spontaneous coughs over a three-day period using a take-home test kit. LuCED kits are shipped to the VisionGate Biosignatures Laboratory (VBL) and then samples are processed on our proprietary Cell-CT technology, a component of LuCED. The first automated 3D cell imaging platform, this revolutionary technology computes sub-micron resolution biosignatures from intact cells. Cell classifiers then automatically identify abnormal cells in sputum. Please view the Cost-Effectiveness study conducted by the University of Arizona.

VisionGate currently has collaborations or pending IRBs with:

NYU Langone Cancer CenterKaiser Permanente
Fred Hutchinson Cancer Research CenterSwedish Cancer Institute
Memorial Sloan KetteringToronto General Hospital
Cancer Treatment Centers of AmericaDignity Health
Oregon Health & Science UniversityUniversity of Navarra (Spain)
Aristotle University (Greece)

To discuss opportunities, please contact VisionGate at 602.354.8862 or send an email to

Related Pages

Notify Me When It Arrives

Complete the fields below to be notified when our LuCED® Lung Cancer Test becomes available.

Your Name (required)

Your Email (required)

Your State (required)

Contact Us

If you are interested in learning more about the VisionGate® Cell-CT™ technology and would like to speak with someone, please complete this short inquiry form and a VisionGate representative will contact you as soon as possible.

Copyright 2017 - VisionGate, Inc.